Provided by Tiger Fintech (Singapore) Pte. Ltd.

Omnicell

29.57
-0.3700-1.24%
Post-market: 30.280.7100+2.40%17:48 EDT
Volume:879.17K
Turnover:25.99M
Market Cap:1.36B
PE:60.00
High:30.13
Open:29.89
Low:29.09
Close:29.94
52wk High:55.75
52wk Low:22.66
Shares:45.93M
Float Shares:44.82M
Volume Ratio:3.37
T/O Rate:1.96%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.4929
EPS(LYR):0.2721
ROE:1.87%
ROA:0.49%
PB:1.07
PE(LYR):108.66

Loading ...

Company Profile

Company Name:
Omnicell
Exchange:
NASDAQ
Establishment Date:
1992
Employees:
3650
Office Location:
4220 North Freeway,Suite 301,Fort Worth,Texas,United States
Zip Code:
76137
Fax:
- -
Introduction:
Omnicell, Inc., together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital, as well as specialized automated dispensing systems for operating room; Omnicell Interface Software that offers interface and integration between its medication-use products or supply products, and a healthcare facility's in-house information management systems; and robotic dispensing systems for handling the stocking and retrieval of boxed medications. It also provides central pharmacy automation solutions; IV compounding robots and workflow management systems; inventory management software; and controlled substance management systems. In addition, the company provides single-dose automation solutions that fill and label a variety of patient-specific, single-dose medication blister packaging based on incoming prescriptions; fully automated and semi-automated filling equipment for institutional pharmacies to warrant automated packaging of medications; and medication blister card packaging and packaging supplies to enhance medication adherence in non-acute care settings. Further, it offers EnlivenHealth Patient Engagement, a web-based nexus of solutions. The company was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc. in 2001. Omnicell, Inc. was incorporated in 1992 and is headquartered in Santa Clara, California.

Directors

Name
Position
Randall A. Lipps
President,Chief Executive Officer and Chairman of the Board
Bruce E. Scott
Director
Edward P. Bousa
Director
Eileen J. Voynick
Director
Kaushik Ghoshal
Director
Mark W. Parrish
Director
Mary Garrett
Director
Robin G. Seim
Director

Shareholders

Name
Position
Randall A. Lipps
President,Chief Executive Officer and Chairman of the Board
Nnamdi Njoku
Executive Vice President and Chief Operating Officer
Baird Radford
Executive Vice President and Chief Financial Officer
Nchacha E. Etta
Executive Vice President and Chief Financial Officer
Corey J. Manley
Executive Vice President and Chief Legal and Administrative Officer
Joanne B. Bauer
Lead Independent